Cargando…

Prognostic Effect of Microenvironment Phenotype in Triple-Negative Breast Cancer: Biomarker Analysis of a Prospective Trial

Background: The microenvironment of triple-negative breast cancer (TNBC) can be divided into three clusters based on bioinformatics-based immunogenomic analysis: the “immune-desert” cluster, the “innate immune-inactivated” cluster, and the “immune-inflamed” cluster. The immune-inflamed cluster is co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Si-Yuan, Ma, Ding, Shao, Zhi-Ming, Yu, Ke-Da
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490613/ https://www.ncbi.nlm.nih.gov/pubmed/34621789 http://dx.doi.org/10.3389/fmolb.2021.752154

Ejemplares similares

Liver Kinase B1 Regulates Remodeling of the Tumor Microenvironment in Triple-Negative Breast Cancer
por: King, Connor T., et al.
Publicado: (2022)

Targeting Triple Negative Breast Cancer With Oncolytic Adenoviruses
por: Green-Tripp, Gabriela, et al.
Publicado: (2022)

The application of exosomes in the treatment of triple-negative breast cancer
por: Weaver, John W., et al.
Publicado: (2022)

NMR-Based Metabolomics Analysis Predicts Response to Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
por: He, Xiangming, et al.
Publicado: (2021)

Tumor Microenvironment Characterization in Breast Cancer Identifies Prognostic and Neoadjuvant Chemotherapy Relevant Signatures
por: Ji, Fei, et al.
Publicado: (2021)

Evaluation of NTRK Gene Fusion by Five Different Platforms in Triple-Negative Breast Carcinoma
por: Wu, Shafei, et al.
Publicado: (2021)

Immunotherapy in triple-negative breast cancer: Insights into tumor immune landscape and therapeutic opportunities
por: Ribeiro, Rita, et al.
Publicado: (2022)

New progress in the role of microRNAs in the diagnosis and prognosis of triple negative breast cancer
por: Fu, Yeqin, et al.
Publicado: (2023)

Machine learning-driven exploration of drug therapies for triple-negative breast cancer treatment
por: Kaushik, Aman Chandra, et al.
Publicado: (2023)

Prognostic Biomarker TP53 Mutations for Immune Checkpoint Blockade Therapy and Its Association With Tumor Microenvironment of Lung Adenocarcinoma
por: Lin, Xinqing, et al.
Publicado: (2020)

CXCL10 is a Tumor Microenvironment and Immune Infiltration Related Prognostic Biomarker in Pancreatic Adenocarcinoma
por: Huang, Huimin, et al.
Publicado: (2021)

TRPV4 is a Prognostic Biomarker that Correlates with the Immunosuppressive Microenvironment and Chemoresistance of Anti-Cancer Drugs
por: Wang, Kai, et al.
Publicado: (2021)

Diaphanous-related formin subfamily: Novel prognostic biomarkers and tumor microenvironment regulators for pancreatic adenocarcinoma
por: Zhang, Bixi, et al.
Publicado: (2022)

CCDC137 Is a Prognostic Biomarker and Correlates With Immunosuppressive Tumor Microenvironment Based on Pan-Cancer Analysis
por: Guo, Lihao, et al.
Publicado: (2021)

CRISPR/Cas9 as a therapeutic tool for triple negative breast cancer: from bench to clinics
por: Tiwari, Prashant Kumar, et al.
Publicado: (2023)

Establishment of a Cell Necroptosis Index to Predict Prognosis and Drug Sensitivity for Patients With Triple-Negative Breast Cancer
por: Xie, Jindong, et al.
Publicado: (2022)

Gene expression profile analysis to discover molecular signatures for early diagnosis and therapies of triple-negative breast cancer
por: Alam, Md Shahin, et al.
Publicado: (2022)

SphK2/S1P Promotes Metastasis of Triple-Negative Breast Cancer Through the PAK1/LIMK1/Cofilin1 Signaling Pathway
por: Shi, Weiwei, et al.
Publicado: (2021)

ANLN Enhances Triple-Negative Breast Cancer Stemness Through TWIST1 and BMP2 and Promotes its Spheroid Growth
por: Maryam, Alishba, et al.
Publicado: (2021)

Triple-Negative Breast Cancer: A Brief Review About Epidemiology, Risk Factors, Signaling Pathways, Treatment and Role of Artificial Intelligence
por: Almansour, Nahlah Makki
Publicado: (2022)

The signature of pyroptosis-related gene prognostic and immune microenvironment in adrenocortical carcinoma
por: Gao, Jun, et al.
Publicado: (2023)

Cell Division Cycle Associated Genes as Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma
por: Jiang, Shan-Shan, et al.
Publicado: (2021)

Sphingosine-1-Phosphate Catabolizing Enzymes Predict Better Prognosis in Triple-Negative Breast Cancer Patients and Correlates With Tumor-Infiltrating Immune Cells
por: Nema, Rajeev, et al.
Publicado: (2021)

Identification of PTK2 as an adverse prognostic biomarker in breast cancer by integrated bioinformatics and experimental analyses
por: Chen, Yanru, et al.
Publicado: (2022)

Identification of therapeutic targets and prognostic biomarkers among frizzled family genes in glioma
por: Huang, Ke, et al.
Publicado: (2023)

Urinary Proteomics Identifying Novel Biomarkers for the Diagnosis and Phenotyping of Carotid Artery Stenosis
por: Wang, Wei, et al.
Publicado: (2021)

Mir-4728 is a Valuable Biomarker for Diagnostic and Prognostic Assessment of HER2-Positive Breast Cancer
por: Rui, Tao, et al.
Publicado: (2022)

Identification of the Prognostic Value of Tumor Microenvironment-Related Genes in Esophageal Squamous Cell Carcinoma
por: Zhang, Donglei, et al.
Publicado: (2020)

Long Non-coding RNA BTG3-7:1 and JUND Co-regulate C21ORF91 to Promote Triple-Negative Breast Cancer Progress
por: Dan, Zheng, et al.
Publicado: (2021)

ARHGAP11A Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric Cancer
por: Fan, Biao, et al.
Publicado: (2021)

TMPRSS2 Serves as a Prognostic Biomarker and Correlated With Immune Infiltrates in Breast Invasive Cancer and Lung Adenocarcinoma
por: Xiao, Xinhua, et al.
Publicado: (2022)

Prognostic and diagnostic values of non-coding RNAs as biomarkers for breast cancer: An umbrella review and pan-cancer analysis
por: Bahramy, Afshin, et al.
Publicado: (2023)

Prognostic Prediction, Immune Microenvironment, and Drug Resistance Value of Collagen Type I Alpha 1 Chain: From Gastrointestinal Cancers to Pan-Cancer Analysis
por: Liu, Yi, et al.
Publicado: (2021)

Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma
por: Bai, Yang, et al.
Publicado: (2021)

Identification and Validation of a Novel Tumor Microenvironment-Related Prognostic Signature of Patients With Hepatocellular Carcinoma
por: Li, Rui, et al.
Publicado: (2022)

LyeTxI-b, a Synthetic Peptide Derived From a Spider Venom, Is Highly Active in Triple-Negative Breast Cancer Cells and Acts Synergistically With Cisplatin
por: de Avelar Júnior, Joaquim Teixeira, et al.
Publicado: (2022)

A Pan-Cancer Landscape of HOX-Related lncRNAs and Their Association With Prognosis and Tumor Microenvironment
por: Shao, Wei, et al.
Publicado: (2021)

KIF18B is a Prognostic Biomarker and Correlates with Immune Infiltrates in Pan-Cancer
por: Qiu, Meng-jun, et al.
Publicado: (2021)

A tumor microenvironment gene set–Based prognostic signature for non-small-cell lung cancer
por: Wen, Yingsheng, et al.
Publicado: (2022)

Over-Expression and Prognostic Significance of FATP5, as a New Biomarker, in Colorectal Carcinoma
por: Geng, Qi-Shun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a631oo5ahlprtm70l2a0poiqhl